{"id":"https://openalex.org/W4282019696","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064","title":"Liquid biopsy (LB)-based comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) for the evaluation of patients with myeloid neoplasms.","display_name":"Liquid biopsy (LB)-based comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) for the evaluation of patients with myeloid neoplasms.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4282019696","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e19064","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024395036","display_name":"Douglas A. Mata","orcid":"https://orcid.org/0000-0002-8059-8668","observed_orcids":["https://orcid.org/0000-0002-8059-8668"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas A Mata","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071505679","display_name":"Mina L. Xu","orcid":"https://orcid.org/0000-0001-9513-245X","observed_orcids":["https://orcid.org/0000-0001-9513-245X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mina L. Xu","raw_affiliation_strings":["Division of Hematopathology, Department of Pathology, Yale School of Medicine, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology, Department of Pathology, Yale School of Medicine, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034381533","display_name":"Vignesh Shanmugam","orcid":"https://orcid.org/0000-0002-2005-9080","observed_orcids":["https://orcid.org/0000-0002-2005-9080"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vignesh Shanmugam","raw_affiliation_strings":["Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, and Cancer Program, Broad Institute of MIT and Harvard, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, and Cancer Program, Broad Institute of MIT and Harvard, Boston, MA;","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027336186","display_name":"Hanna Tukachinsky","orcid":"https://orcid.org/0000-0002-0777-7555","observed_orcids":["https://orcid.org/0000-0002-0777-7555"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hanna Tukachinsky","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062019987","display_name":"Alexa Betzig Schrock","orcid":"https://orcid.org/0000-0003-0106-9096","observed_orcids":["https://orcid.org/0000-0003-0106-9096"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa Betzig Schrock","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088559019","display_name":"Jeffrey S. Ross","orcid":"https://orcid.org/0000-0001-8494-2596","observed_orcids":["https://orcid.org/0000-0001-8494-2596"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Ross","raw_affiliation_strings":["Foundation Medicine, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052864235","display_name":"Erik Abraham Williams","orcid":"https://orcid.org/0000-0002-9190-2450","observed_orcids":["https://orcid.org/0000-0002-9190-2450"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Abraham Williams","raw_affiliation_strings":["Department of Pathology, University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043379778","display_name":"Meagan Montesion","orcid":"https://orcid.org/0000-0001-9155-556X","observed_orcids":["https://orcid.org/0000-0001-9155-556X"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meagan Montesion","raw_affiliation_strings":["Foundation Medicine Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105217687","display_name":"Brennan James Decker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brennan J. Decker","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035082626","display_name":"Jo\u2010Anne Vergilio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jo-Anne Vergilio","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045665778","display_name":"Geoffrey R. Oxnard","orcid":"https://orcid.org/0000-0003-1054-8240","observed_orcids":["https://orcid.org/0000-0003-1054-8240"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey R. Oxnard","raw_affiliation_strings":["Foundation Medicine, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067777900","display_name":"Jamal K. Benhamida","orcid":"https://orcid.org/0000-0001-5542-9857","observed_orcids":["https://orcid.org/0000-0001-5542-9857"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamal K. Benhamida","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e19064","last_page":"e19064"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.19059999287128448,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liquid-biopsy","display_name":"liquid biopsy","score":0.996999979019165},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9929999709129333},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.968999981880188},{"id":"https://openalex.org/keywords/histiocytic-neoplasms","display_name":"histiocytic neoplasms","score":0.9649999737739563},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9900000095367432},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":1.0},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.6050000190734863},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.6449999809265137},{"id":"https://openalex.org/keywords/ras-raf-mek-pathway","display_name":"RAS/RAF/MEK pathway","score":0.8500000238418579},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.4749999940395355},{"id":"https://openalex.org/keywords/neurofibromatosis-type-1","display_name":"neurofibromatosis type 1","score":0.6740000247955322},{"id":"https://openalex.org/keywords/mek1","display_name":"MEK1","score":0.7699999809265137},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8459787368774414},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.655646562576294},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.6266709566116333},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5601032376289368},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.5392277836799622},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48035964369773865},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.42664140462875366},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3663351237773895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32502198219299316},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3224663734436035},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.32198113203048706},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3218909502029419},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.18178433179855347}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e19064","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e19064","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334461","display_name":"Foundation Medicine","ror":"https://ror.org/02ackr434"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4286298685","https://openalex.org/W4392299377","https://openalex.org/W4310120309","https://openalex.org/W3211378100","https://openalex.org/W4282943291","https://openalex.org/W3095108692","https://openalex.org/W4405054359","https://openalex.org/W7162695016","https://openalex.org/W3087410939","https://openalex.org/W2613505186"],"abstract_inverted_index":{"e19064":[0],"Background:":[1],"LB-based":[2],"CGP":[3,22,384],"of":[4,14,30,44,146,221,289,385,398],"ctDNA":[5],"can":[6,401],"facilitate":[7,411],"the":[8,37,72,133,178,386],"diagnosis,":[9,340],"molecular":[10],"profiling,":[11],"and":[12,94,116,164,188,233,245,264,280,282,292,324,348,413],"monitoring":[13,412],"patients":[15,48,298,332],"with":[16,159,277,333],"myeloid":[17,63,108,370],"neoplasia,":[18,371],"particularly":[19],"when":[20,383],"standard":[21],"is":[23,392],"not":[24,174],"feasible":[25],"due":[26],"to":[27,50],"a":[28,334,337,357,373],"lack":[29],"circulating":[31],"disease":[32,416],"or":[33,39,61,83,303,359,381,390,406],"insufficient":[34],"tumor":[35,339],"in":[36,143,218,223,253,297,369],"marrow":[38],"tissue.":[40],"Methods:":[41],"Retrospective":[42],"study":[43],"LB":[45,335,363,400],"samples":[46,101],"from":[47,107],"reported":[49],"have":[51],"histiocytic":[52],"neoplasms":[53,59],"(HNs),":[54],"myelodysplastic":[55],"syndrome":[56],"(MDS),":[57],"myeloproliferative":[58],"(MPN),":[60],"acute":[62],"leukemia":[64],"(AML)":[65],"tested":[66],"using":[67,71],"hybrid-capture":[68],"next-generation":[69],"sequencing":[70],"FoundationOne":[73,79],"Liquid":[74,80],"CDx":[75],"(targeting":[76],"324":[77],"genes),":[78,82],"(70":[81],"FoundationACT":[84],"(62":[85],"genes)":[86],"assays":[87],"during":[88],"routine":[89],"clinical":[90],"care":[91],"between":[92],"5/2016":[93],"9/2021.":[95],"Results:":[96],"Among":[97],"48,459":[98],"unique":[99],"patient":[100],"submitted":[102],"for":[103,136,301,336],"CGP,":[104],"83":[105],"were":[106,141,192,227,353],"neoplasia:":[109],"34":[110],"HN,":[111],"23":[112],"MDS,":[113],"15":[114],"MPN,":[115],"11":[117],"AML.":[118],"The":[119,148],"median":[120,149,169],"cell-free":[121],"DNA":[122],"yield":[123],"was":[124,155,271],"74.9":[125],"ng":[126],"(interquartile":[127],"range":[128],"[IQR]:":[129],"52.0-167.4),":[130],"well":[131],"above":[132],"minimum":[134],"needed":[135],"analysis.":[137],"Reportable":[138],"pathogenic":[139,185,190,225,251],"alterations":[140,217,226,252,368],"detected":[142,193,236,286],"62.7%":[144],"(52/83)":[145],"cases.":[147],"maximum":[150],"somatic":[151],"allele":[152,196],"frequency":[153,197],"(MSAF)":[154],"17.0%":[156],"(IQR:":[157],"1.7-49.0%),":[158],"AML":[160,248,275],"(45.7%),":[161],"MDS":[162,302],"(25.9%),":[163],"MPN":[165,304],"(43.8%)":[166],"having":[167],"higher":[168],"MSAFs":[170],"than":[171],"HNs":[172,212],"(3.2%),":[173],"unexpected":[175],"given":[176],"that":[177,376],"former":[179],"naturally":[180],"circulate.":[181],"In":[182],"all,":[183],"147":[184],"short":[186],"variants":[187],"6":[189],"rearrangements":[191],"(median":[194],"variant":[195],"[VAF]:":[198],"2.1%,":[199],"IQR:":[200],"0.3-20.5%,":[201],"range:":[202],"0.11-99.8%).":[203],"Sixty-one":[204],"had":[205],"VAFs":[206,238,288],"<":[207],"1.0%,":[208],"indicating":[209,356],"excellent":[210],"sensitivity.":[211],"exhibited":[213,250],"activating":[214],"RAS-RAF-MEK":[215],"pathway":[216],"BRAF":[219],"(31.3%":[220],"cases":[222,249],"which":[224,409],"identified),":[228],"NF1":[229],"(12.5%),":[230],"MAP2K1":[231],"(6.3%),":[232,235],"NRAS":[234,265,283],"at":[237,287],"as":[239,241],"low":[240,396],"0.21%,":[242],"0.13%,":[243],"0.11%,":[244],"4.0%,":[246],"respectively.":[247,294],"TP53":[254,306],"(57.1%),":[255],"FLT3":[256],"(28.6%),":[257,259,261],"IDH2":[258],"NPM1":[260],"KRAS":[262,278],"(14.3%),":[263,266],"among":[267,327,330],"others.":[268,328],"Subclonal":[269],"heterogeneity":[270],"identified,":[272],"including":[273],"an":[274],"case":[276],"G12A":[279,284],"G13R":[281],"mutations":[285,352],"0.24%,":[290],"0.19%,":[291],"0.2%,":[293],"Altered":[295],"genes":[296],"undergoing":[299],"workup":[300],"included":[305],"(41.4%),":[307],"JAK2":[308,342],"(37.9%),":[309],"DNMT3A":[310],"(13.8%),":[311],"CHEK2":[312],"(10.3%),":[313,315,317,319],"PTPN11":[314],"SF3B1":[316],"TET2":[318],"ASXL1":[320],"(6.9%),":[321],"MPL":[322,350],"(3.5%),":[323,326],"U2AF1":[325],"Last,":[329],"48,243":[331],"solid":[338],"3,487":[341],"V617F,":[343],"366":[344],"CALR":[345],"C-terminal":[346],"truncation,":[347],"343":[349],"W515X":[351],"detected,":[354],"potentially":[355],"concurrent":[358],"occult":[360],"MPN.":[361],"Conclusions:":[362],"identified":[364],"clinically":[365],"relevant":[366],"genomic":[367],"offering":[372],"powerful":[374],"tool":[375],"may":[377,410],"be":[378],"used":[379],"pre-":[380],"post-treatment":[382],"buffy":[387],"coat,":[388],"marrow,":[389],"tissue":[391],"infeasible.":[393],"Given":[394],"its":[395],"limit":[397],"detection,":[399],"also":[402],"identify":[403],"low-level":[404],"emerging":[405],"persistent":[407],"subclones,":[408],"minimal":[414],"residual":[415],"testing.":[417]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2022-06-13T00:00:00"}